- Home
- PHGE vs EQS Comparison
PHGE vs EQS Comparison
Compare PHGE & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- EQS
- Stock Information
- Founded
- PHGE 2015
- EQS 1991
- Country
- PHGE Israel
- EQS United States
- Employees
- PHGE N/A
- EQS N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- PHGE Health Care
- EQS Finance
- Exchange
- PHGE Nasdaq
- EQS Nasdaq
- Market Cap
- PHGE 13.3M
- EQS 13.9M
- IPO Year
- PHGE N/A
- EQS N/A
- Fundamental
- Price
- PHGE $0.59
- EQS $1.00
- Analyst Decision
- PHGE Strong Buy
- EQS
- Analyst Count
- PHGE 2
- EQS 0
- Target Price
- PHGE $23.00
- EQS N/A
- AVG Volume (30 Days)
- PHGE 200.7K
- EQS 4.5K
- Earning Date
- PHGE 05-19-2025
- EQS 01-01-0001
- Dividend Yield
- PHGE N/A
- EQS N/A
- EPS Growth
- PHGE N/A
- EQS N/A
- EPS
- PHGE N/A
- EQS N/A
- Revenue
- PHGE N/A
- EQS $1,274,000.00
- Revenue This Year
- PHGE N/A
- EQS N/A
- Revenue Next Year
- PHGE N/A
- EQS N/A
- P/E Ratio
- PHGE N/A
- EQS N/A
- Revenue Growth
- PHGE N/A
- EQS 411.65
- 52 Week Low
- PHGE $0.48
- EQS $0.87
- 52 Week High
- PHGE $4.99
- EQS $1.53
- Technical
- Relative Strength Index (RSI)
- PHGE 51.14
- EQS 45.90
- Support Level
- PHGE $0.52
- EQS $0.93
- Resistance Level
- PHGE $0.57
- EQS $1.06
- Average True Range (ATR)
- PHGE 0.05
- EQS 0.05
- MACD
- PHGE 0.01
- EQS 0.01
- Stochastic Oscillator
- PHGE 62.83
- EQS 68.42
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invest primarily in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts and recapitalizations of existing businesses or special situations and achieve capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.